Starks Daniel J's Form 4 filing
Abbott Laboratories (ABT) · filed Oct 30, 2023
- Accession no.
- 0001104659-23-112618
- Filed
- Oct 30, 2023
- Trade date
- Oct 26, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $4.70M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Starks Daniel JCIK 0000902132 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 26, 2023 | Common shares without par value | SSaleDisposed | −26,907 | $93.81 | −$2,524,145.67 | 6,748,409 | Direct | |
| Oct 26, 2023 | Common shares without par value | SSaleDisposed | −23,093 | $94.33 | −$2,178,362.69 | 6,725,316 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.